Cargando…
Kinetics of Severity Biomarkers and Immunological Features of Methylprednisolone Therapy for Severe COVID-19 Patients
In contrast to dexamethasone, the clinical efficacy of methylprednisolone (MP) remains controversial, and a systems biology study on its mechanism is lacking. In this study, a total of 38 severe COVID-19 patients were included. The demographics, clinical characteristics, and severity biomarkers incl...
Autores principales: | Fan, Qinghong, Deng, Kai, Huang, Huang, He, Ruiying, Deng, Xizi, Lan, Yun, Tan, Yizhou, Chen, Weilie, Wang, Yaping, Deng, Xilong, Hu, Fengyu, Li, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957869/ https://www.ncbi.nlm.nih.gov/pubmed/35350784 http://dx.doi.org/10.3389/fimmu.2022.758946 |
Ejemplares similares
-
Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity
por: Chen, Weilie, et al.
Publicado: (2020) -
Absence of Integrase Inhibitor-Associated Resistance Among Antiretroviral Therapy-Naïve HIV-1-Infected Adults in Guangdong Province, China, in 2018
por: Lan, Yun, et al.
Publicado: (2020) -
Transmission, viral kinetics and clinical characteristics of the emergent SARS-CoV-2 Delta VOC in Guangzhou, China
por: Wang, Yaping, et al.
Publicado: (2021) -
Prognostic Factors for COVID-19 Pneumonia Progression to Severe Symptoms Based on Earlier Clinical Features: A Retrospective Analysis
por: Huang, Huang, et al.
Publicado: (2020) -
Successful use of methylprednisolone for treating severe COVID-19
por: Liu, Jing, et al.
Publicado: (2020)